<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27884851</article-id><article-id pub-id-type="pmc">5168541</article-id><article-id pub-id-type="publisher-id">bmjopen-2016-013314</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2016-013314</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cardiovascular Medicine</subject><subj-group><subject>Research</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1683</subject><subject>1691</subject></subj-group></article-categories><title-group><article-title>Influence of preinfarction angina and coronary collateral blood flow on the efficacy of remote ischaemic conditioning in patients with ST segment elevation myocardial infarction: post hoc subgroup analysis of a randomised controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pryds</surname><given-names>Kasper</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>B&#x000f8;ttcher</surname><given-names>Morten</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Sloth</surname><given-names>Astrid Drivsholm</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Munk</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rahbek Schmidt</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>B&#x000f8;tker</surname><given-names>Hans Erik</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><on-behalf-of>on behalf of the CONDI Investigators</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="collab"><name><surname>Kharbanda</surname><given-names>R</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Kaltoft</surname><given-names>AK</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Terkelsen</surname><given-names>CJ</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Andersen</surname><given-names>NH</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Hansen</surname><given-names>TM</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Trautner</surname><given-names>S</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Lassen</surname><given-names>JF</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Christiansen</surname><given-names>EH</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Krusell</surname><given-names>LR</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Kristensen</surname><given-names>SD</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Thuesen</surname><given-names>L</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Nielsen</surname><given-names>SS</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Rehling</surname><given-names>M</given-names></name></contrib><contrib contrib-type="collab"><name><surname>S&#x000f8;rensen</surname><given-names>HT</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Redington</surname><given-names>AN</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Nielsen</surname><given-names>TT</given-names></name></contrib></contrib-group><aff id="af1"><label>1</label><addr-line>Department of Cardiology</addr-line>, <institution>Aarhus University Hospital Skejby</institution>, <addr-line>Aarhus</addr-line>, <country>Denmark</country></aff><aff id="af2"><label>2</label><institution>Institute of Clinical Medicine, Aarhus University</institution>, <addr-line>Aarhus</addr-line>, <country>Denmark</country></aff><aff id="af3"><label>3</label><addr-line>Department of Internal Medicine</addr-line>, <institution>Hospital Unit West</institution>, <addr-line>Herning</addr-line>, <country>Denmark</country></aff><author-notes><corresp><label>Correspondence to</label> Dr Kasper Pryds; <email>kpryds@clin.au.dk</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2016</year></pub-date><volume>6</volume><issue>11</issue><elocation-id>e013314</elocation-id><history><date date-type="received"><day>4</day><month>7</month><year>2016</year></date><date date-type="rev-recd"><day>3</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjopen-2016-013314.pdf"/><abstract><sec><title>Objectives</title><p>Remote ischaemic conditioning (RIC) confers cardioprotection in patients with ST segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). We investigated whether preinfarction angina and coronary collateral blood flow (CCBF) to the infarct-related artery modify the efficacy of RIC.</p></sec><sec><title>Design</title><p>Post hoc subgroup analysis of a randomised controlled trial.</p></sec><sec><title>Participants</title><p>A total of 139 patients with STEMI randomised to treatment with pPCI or RIC+pPCI.</p></sec><sec><title>Interventions</title><p>RIC was performed prior to pPCI as four cycles of 5&#x02005;min upper arm ischaemia and reperfusion with a blood pressure cuff.</p></sec><sec><title>Primary outcome measure</title><p>Myocardial salvage index (MSI) assessed by single-photon emission computerised tomography. We evaluated the efficacy of RIC in subgroups of patients with or without preinfarction angina or CCBF.</p></sec><sec><title>Results</title><p>Of 139 patients included in the study, 109 had available data for preinfarction angina status and 54 had preinfarction angina. Among 83 patients with Thrombolysis In Myocardial Infarction flow 0/1 on arrival, 43 had CCBF. Overall, RIC+pPCI increased median MSI compared with pPCI alone (0.75 vs 0.56, p=0.045). Mean MSI did not differ between patients with and without preinfarction angina in either the pPCI alone (0.58 and 0.57; 95% CI &#x02212;0.17 to 0.19, p=0.94) or the RIC+pPCI group (0.66 and 0.69; 95% CI &#x02212;0.18 to 0.10, p=0.58). Mean MSI did not differ between patients with and without CCBF in the pPCI alone group (0.51 and 0.55; 95% CI &#x02212;0.20 to 0.13, p=0.64), but was increased in patients with CCBF versus without CCBF in the RIC+pPCI group (0.75 vs 0.58; 95% CI 0.03 to 0.31, p=0.02; effect modification from CCBF on the effect of RIC on MSI, p=0.06).</p></sec><sec><title>Conclusions</title><p>Preinfarction angina did not modify the efficacy of RIC in patients with STEMI undergoing pPCI. CCBF to the infarct-related artery seems to be of importance for the cardioprotective efficacy of RIC.</p></sec><sec><title>Trial registration number</title><p><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT00435266?term=NCT00435266&#x00026;rank=1">NCT00435266</ext-link>, Post-results.</p></sec></abstract></article-meta></front><body><boxed-text position="float" orientation="portrait"><caption><title>Strengths and limitations of this study</title></caption><list list-type="bullet"><list-item><p>Potential inherent cardioprotective effect from preinfarction angina and coronary collateral blood flow (CCBF) to the infarct-related artery may modify the efficacy of adjunctive treatment strategies in patients with ST segment elevation myocardial infarction (STEMI).</p></list-item><list-item><p>This is the first evaluation of the influence of preinfarction angina and CCBF to the infarct-related artery on the efficacy of remote ischaemic conditioning (RIC) prior to primary percutaneous coronary intervention (PCI) in patients with STEMI.</p></list-item><list-item><p>We found that preinfarction angina does not seem to modify the efficacy of RIC, but CCBF to the infarct-related artery seems of importance for the cardioprotective efficacy of RIC.</p></list-item><list-item><p>Our findings implicate that RIC could be initiated in all patients with STEMI referred for primary PCI even with a history of preinfarction angina and at the time when the CCBF status is unknown.</p></list-item><list-item><p>Because of limited statistical power, this post hoc analysis should be considered explorative.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p>Reperfusion injury following restoration of coronary blood flow by primary percutaneous coronary intervention (pPCI) or thrombolysis adds significantly to the ischaemic damage of the myocardium in patients with acute myocardial infarction.<xref rid="R1" ref-type="bibr">1</xref> Remote ischaemic conditioning (RIC) is a mechanical cardioprotective strategy conferred by short-term intermittent periods of ischaemia and reperfusion of the upper extremity induced by inflations and deflations of a blood pressure cuff.<xref rid="R2" ref-type="bibr">2</xref> RIC has emerged as a promising strategy against ischaemia&#x02013;reperfusion injury in patients with ST segment elevation myocardial infarction (STEMI)<xref rid="R2" ref-type="bibr">2</xref> and may translate into improved long-term clinical outcome.<xref rid="R3" ref-type="bibr">3</xref> However, in patients with STEMI, potential inherent cardioprotective effects from preinfarction angina<xref rid="R4" ref-type="bibr">4</xref>
<xref rid="R5" ref-type="bibr">5</xref> and coronary collateral blood flow (CCBF) to the infarct-related artery<xref rid="R6" ref-type="bibr">6&#x02013;8</xref> may attenuate the beneficial effect from RIC. We aimed to investigate whether preinfarction angina and CCBF modify the cardioprotective efficacy of RIC in patients with STEMI undergoing pPCI.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Study design and participants</title><p>We performed a post hoc analysis of a single-centre, randomised controlled trial at the Department of Cardiology, Aarhus University Hospital, Denmark.<xref rid="R9" ref-type="bibr">9</xref> The study protocol and patient randomisation have previously been described in detail.<xref rid="R9" ref-type="bibr">9</xref> In brief, a total of 333 patients were enrolled between February 2007 and November 2008. Inclusion criteria were (1) age &#x02265;18&#x02005;years, (2) duration of symptoms &#x02264;12&#x02005;hours prior to admission and (3) ST segment elevation &#x02265;0.1&#x02005;mV in two or more contiguous electrocardiogram leads. Exclusion criteria from data analysis were (1) diagnosis not confirmed on arrival to the hospital, (2) history of previous myocardial infarction, (3) history of previous coronary artery bypass surgery and (4) chest pain &#x0003e;12&#x02005;hours prior to admission.</p><p>Patients with a tentative diagnosis of STEMI were randomised to standard treatment with pPCI or treatment with RIC preceding pPCI. RIC was initiated in the ambulance during transportation to the hospital and performed as four cycles of 5&#x02005;min upper arm ischaemia followed by 5&#x02005;min of reperfusion using a standard blood pressure cuff inflated to 200&#x02005;mm&#x02005;Hg.</p></sec><sec id="s2b"><title>Study end point</title><p>The study end point was myocardial salvage index (MSI) on day 30 following pPCI and was obtained from single-photon emission computerised tomography (SPECT) imaging on arrival and on day 30. Patients received <sup>99</sup>Technetium sestamibi intravenously prior to pPCI followed by SPECT imaging within 8&#x02005;hours of injection to quantify myocardial area-at-risk of infarction. On day 30 following pPCI, a similar SPECT imaging protocol was performed 1&#x02005;hour after tracer injection to quantify final infarct size. Myocardial area-at-risk of infarction and final infarct size were determined as the percentage of the left ventricle. MSI expresses the proportion of the myocardium at risk of infarction being salvaged by the assigned treatment, and was calculated as: (area-at-risk&#x000f7;final infarct size)/area-at-risk. Experienced nuclear cardiology readers who were blinded to treatment assignment and clinical data analysed SPECT imaging data.</p></sec><sec id="s2c"><title>Data collection</title><p>All randomised patients from the parent trial fulfilling the inclusion criteria and with available data for MSI were included in the present study.</p><p>All patients regardless of Thrombolysis In Myocardial Infarction (TIMI) flow on arrival constituted the preinfarction angina study cohort. Preinfarction angina was defined as &#x02265;1 episodes of angina within 48&#x02005;hours prior to the STEMI. Information concerning preinfarction angina was collected retrospectively from patient medical records. Patients for which no such information was available were excluded from data analysis.</p><p>Only patients with TIMI flow 0/1 on arrival constituted the coronary collateral study cohort. Preprocedural CCBF to the infarct-related artery was assessed on the pre-pPCI coronary angiogram and classified in accordance with the Rentrop grading system<xref rid="R10" ref-type="bibr">10</xref> by two dedicated observers blinded to treatment allocation and clinical data. Both observers assessed the coronary angiogram and a consensus was reached. The Rentrop grading system provides a score for the spontaneously visible or recruitable coronary collateral circulation following occlusion of the coronary vessel.<xref rid="R11" ref-type="bibr">11</xref> Collateral filling of the infarct-related artery was visibly assessed and assigned a score as follows: 0=no filling, 1=filling of the side branches, 2=partial filling of the epicardial segment and 3=complete filling of the epicardial segment. Patients were grouped as either having CCBF (Rentrop score 1&#x02013;3) or no CCBF (Rentrop score 0).</p><p>Healthcare system delay was obtained from emergency medical service-related and pPCI-related registries and files, and defined as time from emergency medical service call to the pPCI wire traversing the culprit lesion. Electrocardiogram recordings provided data for achieved 70% or more ST segment resolution within 90&#x02005;min after first pPCI wire.</p><p>The parent trial was conducted in accordance with the Declaration of Helsinki (2000) of the World Medical Association, approved by the local ethics committee and registered with <ext-link ext-link-type="uri" xlink:href="clinicaltrials.gov">clinicaltrials.gov</ext-link> (NCT00435266). Written informed consent was obtained from all participants prior to inclusion.</p></sec><sec id="s2d"><title>Statistical analysis</title><p>STATA/SE V.13 (StataCorp, College Station, Texas, USA) and GraphPad PRISM V.6 (GraphPad Software, La Jolla, California, USA) were used for statistical analysis. Data were tested for normal distribution and equality of variance prior to analysis. Continuous variables were compared by Student's t-test or Mann-Whitney U test for parametric and non-parametric data. Categorical variables were compared with the &#x003c7;<sup>2</sup> test or Fisher's exact test. Simple linear regression analysis was used for crude effect modification analysis, that is, test for interaction. We performed additional multiple linear regression analyses with adjustment for potential confounding variables that could influence on MSI, that is, preprocedural vessel patency (TIMI flow 0/1 vs 2/3),<xref rid="R7" ref-type="bibr">7</xref> healthcare system delay (minutes),<xref rid="R12" ref-type="bibr">12</xref> treatment allocation (pPCI alone vs RIC+pPCI)<xref rid="R9" ref-type="bibr">9</xref> and any baseline variable with a p value of &#x0003c;0.05 in between the studied groups. We justified the use of linear regression models by checking variance of error, the distribution of variance and a normal distribution of residuals prior to their application. We used Spearman's rank correlation analysis to determine the correlation between the degree of CCBF, that is, the Rentrop score, and MSI in patients treated with pPCI alone or RIC+pPCI.</p><p>Data are expressed as number (%), mean (SD) with 95% CI for the difference in mean or median (IQR). For multiple linear regression analyses, data are expressed as regression coefficient with 95% CI for the regression coefficient. For Spearman's rank correlation analysis, data are expressed as the Spearman correlation coefficient, &#x003c1;. Statistical significance was set as two-sided p value of &#x0003c;0.05.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3a"><title>Baseline characteristics</title><p>Of 333 patients enrolled in the parent trial, 251 patients were eligible for trial imaging follow-up. Of these, 111 patients did not achieve both SPECT scans necessary for MSI calculation. One patient was excluded from data analysis due to re-infarction between first and second SPECT scan resulting in unreliable MSI data. Consequently, data for MSI were available for a total of 139 patients (pPCI alone n=68 and RIC+pPCI n=71; <xref ref-type="fig" rid="BMJOPEN2016013314F1">figure 1</xref>). Of these, 129 patients had available data for healthcare system delay (pPCI alone n=66 and RIC+pPCI n=63) and 131 patients had available data for achieved 70% ST segment resolution (pPCI alone n=64 and RIC+pPCI n=67). Baseline and procedural variables, including achieved post-pPCI TIMI flow and 70% ST segment resolution, were similar in the treatment groups except for hypertension, which was more common among patients treated with RIC+pPCI (<xref ref-type="table" rid="BMJOPEN2016013314TB1">table 1</xref>).</p><table-wrap id="BMJOPEN2016013314TB1" orientation="portrait" position="float"><label>Table&#x000a0;1</label><caption><p>Baseline characteristics and procedural data for all patients</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">pPCI alone (n=68)</th><th align="left" rowspan="1" colspan="1">RIC+pPCI (n=71)</th><th align="left" rowspan="1" colspan="1">p Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Men</td><td rowspan="1" colspan="1">55 (81%)</td><td rowspan="1" colspan="1">57 (80%)</td><td rowspan="1" colspan="1">0.93</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">62 (11)</td><td rowspan="1" colspan="1">63 (11)</td><td rowspan="1" colspan="1">0.56</td></tr><tr><td rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">25 (23&#x02013;29)</td><td rowspan="1" colspan="1">26 (24&#x02013;29)</td><td rowspan="1" colspan="1">0.55</td></tr><tr><td rowspan="1" colspan="1">Current smokers</td><td rowspan="1" colspan="1">38 (56%)</td><td rowspan="1" colspan="1">34 (48%)</td><td rowspan="1" colspan="1">0.30</td></tr><tr><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">19 (28%)</td><td rowspan="1" colspan="1">32 (45%)</td><td rowspan="1" colspan="1">0.04</td></tr><tr><td rowspan="1" colspan="1">Diabetes mellitus</td><td rowspan="1" colspan="1">8 (12%)</td><td rowspan="1" colspan="1">6 (8%)</td><td rowspan="1" colspan="1">0.52</td></tr><tr><td colspan="4" rowspan="1">Preinfarction medication</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Aspirin</td><td rowspan="1" colspan="1">12 (18%)</td><td rowspan="1" colspan="1">12 (17%)</td><td rowspan="1" colspan="1">0.94</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x003b2; blockers</td><td rowspan="1" colspan="1">10 (15%)</td><td rowspan="1" colspan="1">11 (15%)</td><td rowspan="1" colspan="1">0.87</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Calcium channel blockers</td><td rowspan="1" colspan="1">8 (12%)</td><td rowspan="1" colspan="1">7 (10%)</td><td rowspan="1" colspan="1">0.74</td></tr><tr><td rowspan="1" colspan="1">&#x02003;ACE inhibitors</td><td rowspan="1" colspan="1">6 (9%)</td><td rowspan="1" colspan="1">14 (20%)</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Angiotensin II receptor blockers</td><td rowspan="1" colspan="1">5 (7%)</td><td rowspan="1" colspan="1">10 (14%)</td><td rowspan="1" colspan="1">0.27</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Long-acting nitrates</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Statins</td><td rowspan="1" colspan="1">12 (18%)</td><td rowspan="1" colspan="1">12 (17%)</td><td rowspan="1" colspan="1">0.91</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Loop diuretics</td><td rowspan="1" colspan="1">2 (3%)</td><td rowspan="1" colspan="1">2 (3%)</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Thiazide diuretics</td><td rowspan="1" colspan="1">12 (18%)</td><td rowspan="1" colspan="1">16 (23%)</td><td rowspan="1" colspan="1">0.45</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Aldosterone antagonists</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Clopidogrel</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td colspan="4" rowspan="1">Procedural data</td></tr><tr><td rowspan="1" colspan="1">&#x02003;TIMI flow 0/1&#x02014;pre-pPCI</td><td rowspan="1" colspan="1">41 (60%)</td><td rowspan="1" colspan="1">42 (59%)</td><td rowspan="1" colspan="1">0.89</td></tr><tr><td rowspan="1" colspan="1">&#x02003;TIMI flow 0/1&#x02014;post-pPCI</td><td rowspan="1" colspan="1">2 (3%)</td><td rowspan="1" colspan="1">1 (1%)</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Area-at-risk (% of left ventricle)</td><td rowspan="1" colspan="1">28 (12&#x02013;41)</td><td rowspan="1" colspan="1">26 (16&#x02013;39)</td><td rowspan="1" colspan="1">0.89</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LAD artery infarction</td><td rowspan="1" colspan="1">28 (41%)</td><td rowspan="1" colspan="1">29 (41%)</td><td rowspan="1" colspan="1">0.91</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Healthcare system delay (min)*</td><td rowspan="1" colspan="1">102 (82&#x02013;139)</td><td rowspan="1" colspan="1">108 (86&#x02013;146)</td><td rowspan="1" colspan="1">0.37</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Achieved 70% ST segment resolution&#x02020;</td><td rowspan="1" colspan="1">44 (69%)</td><td rowspan="1" colspan="1">49 (73%)</td><td rowspan="1" colspan="1">0.58</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean (SD), median (IQR) or number (%).</p></fn><fn><p>*Data for healthcare system delay were missing for 10 patients.</p></fn><fn><p>&#x02020;Data for achieved 70% ST segment resolution were missing for eight patients.</p></fn><fn><p>LAD, left anterior descending; pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning; TIMI, Thrombolysis In Myocardial Infarction.</p></fn></table-wrap-foot></table-wrap><fig id="BMJOPEN2016013314F1" orientation="portrait" position="float"><label>Figure&#x000a0;1</label><caption><p>Study flow chart for patients included in the preinfarct angina and coronary collateral study cohorts. See text for details. CCBF, coronary collateral blood flow; MSI, myocardial salvage index; pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning; SPECT, single-photon emission computerised tomography; TIMI, Thrombolysis In Myocardial Infarction.</p></caption><graphic xlink:href="bmjopen2016013314f01"/></fig><p>Overall, RIC+pPCI increased median MSI compared with pPCI alone (0.75 (IQR: 0.50&#x02013;0.93) vs 0.56 (IQR: 0.35&#x02013;0.89), p=0.045), including in a multiple linear regression analysis with adjustment for healthcare system delay, preprocedural vessel patency and hypertension (0.11 increase in MSI from RIC+pPCI; 95% CI 0.004 to 0.21, p=0.04).</p></sec><sec id="s3b"><title>Prevalence of preinfarction angina and influence on the efficacy of RIC</title><p>A total of 109 patients had available information concerning preinfarct angina; of which, 54 (50%) patients had preinfarction angina within 48&#x02005;hours preceding the STEMI, whereas 55 (50%) did not (<xref ref-type="fig" rid="BMJOPEN2016013314F1">figure 1</xref>). Baseline characteristics, procedural data, including achieved post-pPCI TIMI flow and 70% ST segment resolution, and treatment allocation did not differ between patients with and without preinfarction angina (<xref ref-type="table" rid="BMJOPEN2016013314TB2">table 2</xref>).</p><table-wrap id="BMJOPEN2016013314TB2" orientation="portrait" position="float"><label>Table&#x000a0;2</label><caption><p>Baseline characteristics and procedural data for patients included in the preinfarct angina study cohort</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">&#x02212;Preinfarct angina (n=55)</th><th align="left" rowspan="1" colspan="1">+Preinfarct angina (n=54)</th><th align="left" rowspan="1" colspan="1">p Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Men</td><td rowspan="1" colspan="1">43 (78%)</td><td rowspan="1" colspan="1">45 (83%)</td><td rowspan="1" colspan="1">0.50</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">64 (11)</td><td rowspan="1" colspan="1">61 (12)</td><td rowspan="1" colspan="1">0.24</td></tr><tr><td rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">26 (4)</td><td rowspan="1" colspan="1">26 (4)</td><td rowspan="1" colspan="1">0.75</td></tr><tr><td rowspan="1" colspan="1">Current smokers</td><td rowspan="1" colspan="1">27 (50%)</td><td rowspan="1" colspan="1">29 (54%)</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">17 (31%)</td><td rowspan="1" colspan="1">19 (35%)</td><td rowspan="1" colspan="1">0.64</td></tr><tr><td rowspan="1" colspan="1">Diabetes mellitus</td><td rowspan="1" colspan="1">5 (9%)</td><td rowspan="1" colspan="1">2 (4%)</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td colspan="4" rowspan="1">Preinfarction medication</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Aspirin</td><td rowspan="1" colspan="1">8 (15%)</td><td rowspan="1" colspan="1">10 (19%)</td><td rowspan="1" colspan="1">0.58</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x003b2; blockers</td><td rowspan="1" colspan="1">10 (19%)</td><td rowspan="1" colspan="1">6 (11%)</td><td rowspan="1" colspan="1">0.30</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Calcium channel blockers</td><td rowspan="1" colspan="1">4 (7%)</td><td rowspan="1" colspan="1">4 (8%)</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">&#x02003;ACE inhibitors</td><td rowspan="1" colspan="1">7 (13%)</td><td rowspan="1" colspan="1">6 (11%)</td><td rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Angiotensin II receptor blockers</td><td rowspan="1" colspan="1">3 (6%)</td><td rowspan="1" colspan="1">7 (13%)</td><td rowspan="1" colspan="1">0.20</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Long-acting nitrates</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Statins</td><td rowspan="1" colspan="1">9 (16%)</td><td rowspan="1" colspan="1">8 (15%)</td><td rowspan="1" colspan="1">0.82</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Loop diuretics</td><td rowspan="1" colspan="1">3 (6%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0.24</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Thiazide diuretics</td><td rowspan="1" colspan="1">8 (15%)</td><td rowspan="1" colspan="1">11 (21%)</td><td rowspan="1" colspan="1">0.42</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Aldosterone antagonists</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Clopidogrel</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td colspan="4" rowspan="1">Procedural data</td></tr><tr><td rowspan="1" colspan="1">&#x02003;TIMI flow 0/1&#x02014;pre-pPCI</td><td rowspan="1" colspan="1">20 (36%)</td><td rowspan="1" colspan="1">24 (44%)</td><td rowspan="1" colspan="1">0.39</td></tr><tr><td rowspan="1" colspan="1">&#x02003;TIMI flow 0/1&#x02014;post-pPCI</td><td rowspan="1" colspan="1">1 (2%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Area-at-risk (% of left ventricle)</td><td rowspan="1" colspan="1">28 (20&#x02013;39)</td><td rowspan="1" colspan="1">27 (12&#x02013;41)</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LAD artery infarction</td><td rowspan="1" colspan="1">27 (49%)</td><td rowspan="1" colspan="1">20 (37%)</td><td rowspan="1" colspan="1">0.20</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Healthcare system delay (min)*</td><td rowspan="1" colspan="1">102 (81&#x02013;141)</td><td rowspan="1" colspan="1">109 (89&#x02013;140)</td><td rowspan="1" colspan="1">0.43</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Achieved 70% ST segment resolution&#x02020;</td><td rowspan="1" colspan="1">35 (70%)</td><td rowspan="1" colspan="1">38 (73%)</td><td rowspan="1" colspan="1">0.73</td></tr><tr><td colspan="4" rowspan="1">Treatment allocation</td></tr><tr><td rowspan="1" colspan="1">&#x02003;RIC+pPCI</td><td rowspan="1" colspan="1">32 (58%)</td><td rowspan="1" colspan="1">27 (50%)</td><td rowspan="1" colspan="1">0.39</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean (SD), median (IQR) or number (%).</p></fn><fn><p>*Data for healthcare system delay were missing for nine patients.</p></fn><fn><p>&#x02020;Data for achieved 70% ST segment resolution were missing for seven patients.</p></fn><fn><p>LAD, left anterior descending; pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning; TIMI, Thrombolysis In Myocardial Infarction.</p></fn></table-wrap-foot></table-wrap><p>Overall, preinfarction angina did not affect mean MSI compared with no preinfarction angina (0.62 (SD: 0.28) and 0.64 (SD: 0.30); 95% CI &#x02212;0.14 to 0.09, p=0.65), including in a multiple linear regression analysis with adjustment for treatment allocation, healthcare system delay and preprocedural vessel patency (&#x02212;0.02 decrease in MSI from preinfarction angina; 95% CI &#x02212;0.13 to 0.09, p=0.73).</p><p>In the preinfarction angina study cohort, RIC+pPCI overall increased mean MSI borderline statistically significant compared with pPCI alone (0.68 (SD: 0.27) and 0.57 (SD: 0.31); 95% CI &#x02212;0.007 to 0.21, p=0.07), including in a multiple linear regression analysis with adjustment for healthcare system delay, preprocedural vessel patency, hypertension and preinfarction angina (0.11 increase in MSI from RIC+pPCI; 95% CI &#x02212;0.003 to 0.23, p=0.056). We found no difference in mean MSI between patients with and without preinfarction angina among those treated with pPCI alone (0.58 (SD: 0.30) and 0.57 (SD: 0.34); 95% CI &#x02212;0.17 to 0.19, p=0.94) or those treated with RIC+pPCI (0.66 (SD: 0.27) and 0.69 (SD: 0.27); 95% CI &#x02212;0.18 to 0.10, p=0.58; <xref ref-type="fig" rid="BMJOPEN2016013314F2">figure 2</xref>). Accordingly, we found no effect modification from preinfarction angina on the effect of RIC on MSI by crude interaction analysis (p=0.69). In a multiple linear regression analysis with adjustment for healthcare system delay and preprocedural vessel patency, MSI did not differ between patients with and without preinfarction angina among those treated with pPCI alone (&#x02212;0.01 decrease in MSI from preinfarction angina; 95% CI &#x02212;0.18 to 0.17, p=0.92) or those treated with RIC+pPCI (&#x02212;0.07 decrease in MSI from preinfarction angina; 95% CI &#x02212;0.22 to 0.08, p=0.32) with no effect modification from preinfarction angina on the effect of RIC on MSI by interaction analysis (p=0.59).</p><fig id="BMJOPEN2016013314F2" orientation="portrait" position="float"><label>Figure&#x000a0;2</label><caption><p>Bar graphs (mean) with whiskers (SD) of myocardial salvage index in categories of patients without preinfarction angina and with preinfarction angina in respect to treatment allocation. See text for details. p Values are based on Student's t-test. pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning.</p></caption><graphic xlink:href="bmjopen2016013314f02"/></fig></sec><sec id="s3c"><title>Prevalence of CCBF to the infarct-related artery and influence on the efficacy of RIC</title><p>Eighty-three patients had TIMI flow 0/1 on arrival; 43 (52%) patients had angiographically visible CCBF, whereas 40 (48%) patients did not (<xref ref-type="fig" rid="BMJOPEN2016013314F1">figure 1</xref>). Except for current smokers, who were more frequent among patients with CCBF, baseline characteristics did not differ between patients with and without CCBF (<xref ref-type="table" rid="BMJOPEN2016013314TB3">table 3</xref>). Procedural variables, including myocardial area-at-risk of infarction and achieved post-pPCI TIMI flow and 70% ST segment resolution, were similar between patients with and without CCBF except for culprit lesion located in the left anterior descending artery, which was more common in patients without CCBF (<xref ref-type="table" rid="BMJOPEN2016013314TB3">table 3</xref>). The prevalence of CCBF did not differ between patients treated with pPCI alone or RIC+pPCI (20/41 (49%) and 23/42 (55%), p=0.59).</p><table-wrap id="BMJOPEN2016013314TB3" orientation="portrait" position="float"><label>Table&#x000a0;3</label><caption><p>Baseline characteristics and procedural data for patients included in the coronary collateral study cohort</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/></colgroup><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">&#x02212;Collateral blood flow (n=40)</th><th align="left" rowspan="1" colspan="1">+Collateral blood flow (n=43)</th><th align="left" rowspan="1" colspan="1">p Value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Men</td><td rowspan="1" colspan="1">34 (85%)</td><td rowspan="1" colspan="1">35 (81%)</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">61 (11)</td><td rowspan="1" colspan="1">62 (10)</td><td rowspan="1" colspan="1">0.57</td></tr><tr><td rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">28 (24&#x02013;29)</td><td rowspan="1" colspan="1">25 (24&#x02013;29)</td><td rowspan="1" colspan="1">0.26</td></tr><tr><td rowspan="1" colspan="1">Current smokers</td><td rowspan="1" colspan="1">15 (38%)</td><td rowspan="1" colspan="1">27 (63%)</td><td rowspan="1" colspan="1">0.02</td></tr><tr><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">11 (28%)</td><td rowspan="1" colspan="1">18 (42%)</td><td rowspan="1" colspan="1">0.17</td></tr><tr><td rowspan="1" colspan="1">Diabetes mellitus</td><td rowspan="1" colspan="1">4 (10%)</td><td rowspan="1" colspan="1">3 (7%)</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td colspan="4" rowspan="1">Preinfarction medication</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Aspirin</td><td rowspan="1" colspan="1">7 (18%)</td><td rowspan="1" colspan="1">9 (21%)</td><td rowspan="1" colspan="1">0.69</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x003b2; blockers</td><td rowspan="1" colspan="1">7 (18%)</td><td rowspan="1" colspan="1">4 (9%)</td><td rowspan="1" colspan="1">0.34</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Calcium channel blockers</td><td rowspan="1" colspan="1">4 (10%)</td><td rowspan="1" colspan="1">4 (9%)</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">&#x02003;ACE inhibitors</td><td rowspan="1" colspan="1">3 (8%)</td><td rowspan="1" colspan="1">8 (19%)</td><td rowspan="1" colspan="1">0.20</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Angiotensin II receptor blockers</td><td rowspan="1" colspan="1">4 (10%)</td><td rowspan="1" colspan="1">5 (12%)</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Long-acting nitrates</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Statins</td><td rowspan="1" colspan="1">7 (18%)</td><td rowspan="1" colspan="1">6 (14%)</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Loop diuretics</td><td rowspan="1" colspan="1">2 (5%)</td><td rowspan="1" colspan="1">1 (2%)</td><td rowspan="1" colspan="1">0.61</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Thiazide diuretics</td><td rowspan="1" colspan="1">6 (15%)</td><td rowspan="1" colspan="1">9 (21%)</td><td rowspan="1" colspan="1">0.48</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Aldosterone antagonists</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Clopidogrel</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td colspan="4" rowspan="1">Procedural data</td></tr><tr><td rowspan="1" colspan="1">&#x02003;TIMI flow 0/1&#x02014;post-pPCI</td><td rowspan="1" colspan="1">1 (3%)</td><td rowspan="1" colspan="1">2 (5%)</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Area-at-risk (% of left ventricle)</td><td rowspan="1" colspan="1">35 (28&#x02013;42)</td><td rowspan="1" colspan="1">34 (24&#x02013;44)</td><td rowspan="1" colspan="1">0.75</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LAD artery infarction</td><td rowspan="1" colspan="1">27 (68%)</td><td rowspan="1" colspan="1">10 (23%)</td><td rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Healthcare system delay (min)*</td><td rowspan="1" colspan="1">115 (87&#x02013;139)</td><td rowspan="1" colspan="1">97 (82&#x02013;140)</td><td rowspan="1" colspan="1">0.24</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Achieved 70% ST segment resolution&#x02020;</td><td rowspan="1" colspan="1">26 (74%)</td><td rowspan="1" colspan="1">30 (71%)</td><td rowspan="1" colspan="1">0.78</td></tr><tr><td colspan="4" rowspan="1">Treatment allocation</td></tr><tr><td rowspan="1" colspan="1">&#x02003;RIC+pPCI</td><td rowspan="1" colspan="1">19 (48%)</td><td rowspan="1" colspan="1">23 (53%)</td><td rowspan="1" colspan="1">0.59</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean (SD), median (IQR) or number (%).</p></fn><fn><p>*Data for healthcare system delay were missing for six patients.</p></fn><fn><p>&#x02020;Data for achieved 70% ST segment resolution were missing for six patients.</p></fn><fn><p>LAD, left anterior descending; pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning; TIMI, Thrombolysis In Myocardial Infarction.</p></fn></table-wrap-foot></table-wrap><p>Overall, the presence of CCBF did not affect mean MSI compared with the absence of CCBF (0.64 (SD: 0.25) and 0.57 (SD: 0.26); 95% CI &#x02212;0.04 to 0.19, p=0.20), including in a multiple linear regression analysis with adjustment for treatment allocation, healthcare system delay, left anterior descending artery infarction and current smoking (0.05 increase in MSI from CCBF; 95% CI &#x02212;0.08 to 0.17, p=0.45).</p><p>In the coronary collateral study cohort, RIC+pPCI overall increased mean MSI compared with pPCI alone (0.67 (SD: 0.24) vs 0.53 (SD: 0.26); 95% CI 0.03 to 0.25, p=0.01), including in a multiple linear regression analysis with adjustment for healthcare system delay, hypertension and CCBF (0.14 increase in MSI from RIC+pPCI; 95% CI 0.03 to 0.25, p=0.01). We found no difference in mean MSI between patients with or without CCBF among those treated with pPCI alone (0.51 (SD: 0.26) and 0.55 (SD: 0.26); 95% CI &#x02212;0.20 to 0.13, p=0.64). In contrast, mean MSI was increased in patients with CCBF compared with patients without CCBF among those treated with RIC+pPCI (0.75 (SD: 0.19) vs 0.58 (SD: 0.27); 95% CI 0.03 to 0.31, p=0.02; <xref ref-type="fig" rid="BMJOPEN2016013314F3">figure 3</xref>). Accordingly, we found a statistically borderline significant effect modification from CCBF on the effect of RIC on MSI by crude interaction analysis (p=0.06), with the presence of CCBF favouring the effect of RIC+pPCI treatment. In a multiple linear regression analysis with adjustment for healthcare system delay, left anterior descending artery infarction and current smoking, MSI did not differ between patients with and without CCBF among those treated with pPCI alone (&#x02212;0.08 decrease in MSI from CCBF; 95% CI &#x02212;0.28 to 0.13, p=0.45). In patients with CCBF, MSI was borderline significantly increased compared with patients without CCBF among those treated with RIC+pPCI (0.14 increase in MSI from CCBF; 95% CI &#x02212;0.01 to 0.30, p=0.07). However, the effect modification from CCBF on the effect of RIC on MSI was not statistically significant by interaction analysis (p=0.14).</p><fig id="BMJOPEN2016013314F3" orientation="portrait" position="float"><label>Figure&#x000a0;3</label><caption><p>Bar graphs (mean) with whiskers (SD) of myocardial salvage index in categories of patients without coronary collateral blood flow and with coronary collateral blood flow in respect to treatment allocation. See text for details. p Values are based on Student's t-test. pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning.</p></caption><graphic xlink:href="bmjopen2016013314f03"/></fig><p>We noticed a statistically borderline significant correlation between the Rentrop score and an increase in MSI among patients treated with RIC+pPCI (&#x003c1;=0.29, p=0.06) but not among patients treated with pPCI alone (&#x003c1;=0.007, p=0.97; <xref ref-type="fig" rid="BMJOPEN2016013314F4">figure 4</xref>). When evaluating patients with limited CCBF only (Rentrop score 1), treatment with RIC+pPCI significantly increased mean MSI compared with pPCI alone (0.76 (SD: 0.21) vs 0.39 (SD: 0.22); 95% CI 0.15 to 0.61, p=0.003).</p><fig id="BMJOPEN2016013314F4" orientation="portrait" position="float"><label>Figure&#x000a0;4</label><caption><p>Bar graphs (mean) with whiskers (SD) of the correlation between the Rentrop coronary collateral blood flow score and myocardial salvage index with respect to treatment allocation. See text for details. p Values are based on Spearman's rank correlation analysis. pPCI, primary percutaneous coronary intervention; RIC, remote ischaemic conditioning.</p></caption><graphic xlink:href="bmjopen2016013314f04"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>The main finding of the present study is that preinfarction angina does not seem to modify the efficacy of RIC in patients with STEMI undergoing pPCI. In contrast, our exploratory post hoc analysis indicates that CCBF to the infarct-related artery seems to influence the cardioprotective efficacy of RIC.</p><p>Preinfarction angina per se may be cardioprotective and improve survival in patients with acute myocardial infarction.<xref rid="R13" ref-type="bibr">13</xref>
<xref rid="R14" ref-type="bibr">14</xref> The development of coronary collaterals<xref rid="R15" ref-type="bibr">15</xref> and activation of an inherent ischaemic preconditioning-like effect<xref rid="R16" ref-type="bibr">16</xref> are potential underlying mechanisms. Mechanisms may vary depending on the timing of preinfarction angina. While the development of functional collateral vessels presumably requires time,<xref rid="R17" ref-type="bibr">17</xref> a preconditioning effect could be almost immediate.<xref rid="R2" ref-type="bibr">2</xref> Consistent with this assumption, patients with unstable angina or preinfarction angina closely preceding the acute myocardial infarction seem to have a more pronounced benefit of preinfarction angina in terms of mortality reduction.<xref rid="R18" ref-type="bibr">18</xref> In patients with STEMI treated with pPCI, preinfarction angina has been found to increase myocardial salvage,<xref rid="R4" ref-type="bibr">4</xref> whereas the effects on infarct size<xref rid="R4" ref-type="bibr">4</xref>
<xref rid="R5" ref-type="bibr">5</xref>
<xref rid="R19" ref-type="bibr">19</xref>
<xref rid="R20" ref-type="bibr">20</xref> and mortality are ambiguous.<xref rid="R20" ref-type="bibr">20</xref>
<xref rid="R21" ref-type="bibr">21</xref> In contrast to L&#x000f8;nborg <italic>et al</italic>,<xref rid="R4" ref-type="bibr">4</xref> we found no overall effect of preinfarction angina on myocardial salvage. Our cohort size and suboptimal retrospective evaluation of preinfarction angina occurrence did not allow stratification of the number and severity of preinfarction angina episodes. Thus, differences in confounding factors or patient comorbidities may explain the discrepant findings.<xref rid="R22" ref-type="bibr">22</xref> Importantly, preinfarction angina prior to the STEMI did not compromise the efficacy of RIC.</p><p>The presence of coronary collateral circulation favours clinical outcome in patients with acute and chronic coronary artery disease.<xref rid="R23" ref-type="bibr">23</xref> In contrast, evidence of a direct cardioprotective effect of CCBF in patients with STEMI has shown conflicting effects on myocardial salvage<xref rid="R4" ref-type="bibr">4</xref>
<xref rid="R7" ref-type="bibr">7</xref> and infarct size.<xref rid="R4" ref-type="bibr">4</xref>
<xref rid="R6" ref-type="bibr">6&#x02013;8</xref> Collateral evolvement occurs as a result of coronary artery obstruction,<xref rid="R17" ref-type="bibr">17</xref> but whether short episodes of myocardial ischaemia itself result in immediate CCBF recruitment remains controversial.<xref rid="R24" ref-type="bibr">24&#x02013;26</xref> While myocardial tolerance to ischaemia from repetitive ischaemic stimuli may correlate with CCBF recruitment,<xref rid="R25" ref-type="bibr">25</xref> myocardial tolerance to ischaemia from exercise-induced angina does not.<xref rid="R26" ref-type="bibr">26</xref> Intuitively, well-established CCBF might inherently translate into infarct size reduction and improved clinical outcome by smaller area-at-risk of infarction. Consistent with previous findings,<xref rid="R4" ref-type="bibr">4</xref>
<xref rid="R7" ref-type="bibr">7</xref>
<xref rid="R8" ref-type="bibr">8</xref> we found that area-at-risk did not differ between patients with and without CCBF to the infarct-related artery, and that CCBF did not affect MSI in patients with STEMI undergoing pPCI. Differences in imaging modalities, such as MRI<xref rid="R4" ref-type="bibr">4</xref> or a combined angiographic&#x02013;MRI protocol,<xref rid="R7" ref-type="bibr">7</xref> may influence quantitative assessment of area-at-risk and MSI and challenge comparison. We used SPECT to delineate area-at-risk and final infarct size to avoid potential bias from tissue oedema, which may vary within the postinfarction period<xref rid="R27" ref-type="bibr">27</xref> leaving MSI estimates by cardiac MRI potential inaccurate.<xref rid="R28" ref-type="bibr">28</xref> Although limited spatial resolution of SPECT imaging may compromise detection of small differences in area-at-risk of infarction, SPECT remains the most validated method for assessment of area-at-risk of infarction. Our findings indicate that CCBF has limited protective effect on myocardial salvage in patients with STEMI.</p><p>While RIC reduced coronary microvascular resistance and increased coronary blood flow in an experimental porcine model,<xref rid="R29" ref-type="bibr">29</xref> RIC neither modified coronary microvascular resistance nor baseline and adenosine-induced hyperaemic coronary blood flow velocity in patients undergoing elective percutaneous coronary intervention.<xref rid="R30" ref-type="bibr">30</xref> It remains uncertain to which extent RIC influences myocardial perfusion and CCBF recruitment. In our study, the presence of visible coronary collaterals did not differ between patients either treated with pPCI alone or RIC+pPCI, suggesting that RIC does not confer cardioprotection by recruitment of the coronary collateral circulation. Importantly, RIC predominantly induced cardioprotection among patients with CCBF. However, cardioprotection from RIC has been demonstrated in a large number of animal models,<xref rid="R2" ref-type="bibr">2</xref> with varying degree of coronary collateral circulation.<xref rid="R31" ref-type="bibr">31</xref> While CCBF may not be critical for achieving cardioprotection by RIC, our findings suggest that the coronary collateral circulation plays a potential role for mediating the effect of RIC in humans. Limited CCBF seems sufficient to confer cardioprotection from RIC, but the efficacy of RIC may be amplified by the degree of CCBF. Cardioprotection from RIC is at least partly mediated through circulating humoral factors generated during the RIC stimulus.<xref rid="R2" ref-type="bibr">2</xref> Our findings are consistent with a CCBF-dependent facilitated delivery of circulating cardioprotective factors to the myocardium threatened by ischaemia&#x02013;reperfusion injury. In addition, the coronary collateral circulation has substantial modifiable vasomotor capacity, which may be involved in protective effects from RIC. Although the absence of CCBF may modify the cardioprotective effect of RIC, no patient group has demonstrated adverse effects from RIC treatment.<xref rid="R32" ref-type="bibr">32</xref> Thus, RIC treatment could be initiated in all patients with STEMI referred for pPCI even when the CCBF status is unknown.</p><sec id="s4a"><title>Limitations</title><p>The present study is a post hoc analysis of a randomised controlled trial. The power calculation of the parent trial was based on MSI as primary end point but was not powered for subgroup analyses, which may introduce risk of type 2 errors. Hence, this study should be considered explorative. In the parent trial, a number of patients were excluded following randomisation or did not obtain data for MSI. However, no indication of selection bias was found when assessed in the parent trial.<xref rid="R9" ref-type="bibr">9</xref></p><p>The uneven distribution of left anterior descending artery infarctions and current smokers between patients with and without CCBF may introduce potential confounding. However, in the parent trial, the cardioprotective effect of RIC was most pronounced in patients with left anterior descending artery infarction,<xref rid="R9" ref-type="bibr">9</xref> and in a recent substudy investigating the same patient population as the present study, smoking attenuated the effect of RIC.<xref rid="R32" ref-type="bibr">32</xref> Consequently, the uneven distribution of left anterior descending artery infarctions and current smokers could only have dragged our findings towards zero.</p><p>Assessment of preinfarction angina depends on symptom recognition and holds risk of re-call bias and misinterpretation of non-cardiac symptoms. Preinfarction ischaemia may be silent. We cannot conclude on ischaemic episodes not recognised by the patients. The Rentrop grading system is semiquantitative but a widely used method for CCBF classification allowing retrospective assessment of CCBF without postponing reperfusion therapy.</p><p>Our study design did not allow evaluation of any causal relationship between the influence of preinfarction angina and CCBF on the efficacy of RIC. Our findings indicate a need for concomitant assessment of the coronary collateral circulation when exploring the mechanisms behind RIC.</p></sec></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>Preinfarction angina did not modify the efficacy of RIC in patients with STEMI undergoing pPCI. In contrast, preprocedural CCBF to the infarct-related artery seems to be of importance for the cardioprotective efficacy of RIC.</p></sec></body><back><fn-group><fn><p><bold>Collaborators:</bold>
<italic>CONDI Investigators:</italic> R Kharbanda, AK Kaltoft, CJ Terkelsen, NH Andersen, TM Hansen, S Trautner, JF Lassen, EH Christiansen, LR Krusell, SD Kristensen, L Thuesen, SS Nielsen, M Rehling, HT S&#x000f8;rensen, AN Redington and TT Nielsen.</p></fn><fn><p><bold>Contributors:</bold> KP, MRS and HEB did the data analysis and drafting of the manuscript. All authors participated in data acquisition and critical revision of the manuscript.</p></fn><fn><p><bold>Funding:</bold> This work was supported by Fondation Leducq (06CVD), the Danish Council for Independent Research (11-108354) and the Danish Council for Strategic Research (11-115818).</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> MRS and HEB are shareholders in CellAegis Devices.</p></fn><fn><p><bold>Ethics approval:</bold> The Danish Committee on Health Research Ethics and The Danish Data Protection Agency.</p></fn><fn><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn><p><bold>Data sharing statement:</bold> Raw data and statistical coding are available from the corresponding author at kpryds@clin.au.dk.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yellon</surname><given-names>DM</given-names></name>, <name><surname>Hausenloy</surname><given-names>DJ</given-names></name></person-group>
<article-title>Myocardial reperfusion injury</article-title>. <source>N Engl J Med</source>
<year>2007</year>;<volume>357</volume>:<fpage>1121</fpage>&#x02013;<lpage>35</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMra071667">doi:10.1056/NEJMra071667</ext-link><pub-id pub-id-type="pmid">17855673</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusch</surname><given-names>G</given-names></name>, <name><surname>B&#x000f8;tker</surname><given-names>HE</given-names></name>, <name><surname>Przyklenk</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Remote ischemic conditioning</article-title>. <source>J Am Coll Cardiol</source>
<year>2015</year>;<volume>65</volume>:<fpage>177</fpage>&#x02013;<lpage>95</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2014.10.031">doi:10.1016/j.jacc.2014.10.031</ext-link><pub-id pub-id-type="pmid">25593060</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloth</surname><given-names>AD</given-names></name>, <name><surname>Schmidt</surname><given-names>MR</given-names></name>, <name><surname>Munk</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention</article-title>. <source>Eur Heart J</source>
<year>2014</year>;<volume>35</volume>:<fpage>168</fpage>&#x02013;<lpage>75</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurheartj/eht369">doi:10.1093/eurheartj/eht369</ext-link><pub-id pub-id-type="pmid">24031025</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f8;nborg</surname><given-names>J</given-names></name>, <name><surname>Kelbaek</surname><given-names>H</given-names></name>, <name><surname>Vejlstrup</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction</article-title>. <source>Eur Heart J Cardiovasc Imaging</source>
<year>2012</year>;<volume>13</volume>:<fpage>433</fpage>&#x02013;<lpage>43</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ejechocard/jer296">doi:10.1093/ejechocard/jer296</ext-link><pub-id pub-id-type="pmid">22207343</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>R</given-names></name>, <name><surname>Henry</surname><given-names>TD</given-names></name>, <name><surname>Traverse</surname><given-names>JH</given-names></name></person-group>
<article-title>Preinfarction angina reduces infarct size in ST-elevation myocardial infarction treated with percutaneous coronary intervention</article-title>. <source>Circ Cardiovasc Interv</source>
<year>2013</year>;<volume>6</volume>:<fpage>52</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCINTERVENTIONS.112.973164">doi:10.1161/CIRCINTERVENTIONS.112.973164</ext-link><pub-id pub-id-type="pmid">23339840</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desch</surname><given-names>S</given-names></name>, <name><surname>Eitel</surname><given-names>I</given-names></name>, <name><surname>Schmitt</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Effect of coronary collaterals on microvascular obstruction as assessed by magnetic resonance imaging in patients with acute ST-elevation myocardial infarction treated by primary coronary intervention</article-title>. <source>Am J Cardiol</source>
<year>2009</year>;<volume>104</volume>:<fpage>1204</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2009.06.031">doi:10.1016/j.amjcard.2009.06.031</ext-link><pub-id pub-id-type="pmid">19840563</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz-Perez</surname><given-names>JT</given-names></name>, <name><surname>Lee</surname><given-names>DC</given-names></name>, <name><surname>Meyers</surname><given-names>SN</given-names></name><etal/></person-group>
<article-title>Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index</article-title>. <source>JACC Cardiovasc Imaging</source>
<year>2010</year>;<volume>3</volume>:<fpage>491</fpage>&#x02013;<lpage>500</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcmg.2010.02.004">doi:10.1016/j.jcmg.2010.02.004</ext-link><pub-id pub-id-type="pmid">20466344</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovize</surname><given-names>M</given-names></name>, <name><surname>Thibault</surname><given-names>H</given-names></name>, <name><surname>Przyklenk</surname><given-names>K</given-names></name></person-group>
<article-title>Myocardial conditioning: opportunities for clinical translation</article-title>. <source>Circ Res</source>
<year>2013</year>;<volume>113</volume>:<fpage>439</fpage>&#x02013;<lpage>50</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCRESAHA.113.300764">doi:10.1161/CIRCRESAHA.113.300764</ext-link><pub-id pub-id-type="pmid">23908331</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f8;tker</surname><given-names>HE</given-names></name>, <name><surname>Kharbanda</surname><given-names>R</given-names></name>, <name><surname>Schmidt</surname><given-names>MR</given-names></name><etal/></person-group>
<article-title>Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial</article-title>. <source>Lancet</source>
<year>2010</year>;<volume>375</volume>:<fpage>727</fpage>&#x02013;<lpage>34</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(09)62001-8">doi:10.1016/S0140-6736(09)62001-8</ext-link><pub-id pub-id-type="pmid">20189026</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rentrop</surname><given-names>KP</given-names></name>, <name><surname>Cohen</surname><given-names>M</given-names></name>, <name><surname>Blanke</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects</article-title>. <source>J Am Coll Cardiol</source>
<year>1985</year>;<volume>5</volume>:<fpage>587</fpage>&#x02013;<lpage>92</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0735-1097(85)80380-6">doi:10.1016/S0735-1097(85)80380-6</ext-link><pub-id pub-id-type="pmid">3156171</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>C</given-names></name>, <name><surname>Balachandran</surname><given-names>KP</given-names></name>, <name><surname>L'Allier</surname><given-names>PL</given-names></name><etal/></person-group>
<article-title>Importance of collateral circulation in coronary heart disease</article-title>. <source>Eur Heart J</source>
<year>2007</year>;<volume>28</volume>:<fpage>278</fpage>&#x02013;<lpage>91</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurheartj/ehl446">doi:10.1093/eurheartj/ehl446</ext-link><pub-id pub-id-type="pmid">17218452</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryds</surname><given-names>K</given-names></name>, <name><surname>Terkelsen</surname><given-names>CJ</given-names></name>, <name><surname>Sloth</surname><given-names>AD</given-names></name><etal/></person-group>
<article-title>Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction</article-title>. <source>Heart</source>
<year>2016</year>;<volume>102</volume>:<fpage>1023</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/heartjnl-2015-308980">doi:10.1136/heartjnl-2015-308980</ext-link><pub-id pub-id-type="pmid">26911520</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezkalla</surname><given-names>SH</given-names></name>, <name><surname>Kloner</surname><given-names>RA</given-names></name></person-group>
<article-title>Ischemic preconditioning and preinfarction angina in the clinical arena</article-title>. <source>Nat Clin Pract Cardiovasc Med</source>
<year>2004</year>;<volume>1</volume>:<fpage>96</fpage>&#x02013;<lpage>102</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncpcardio0047">doi:10.1038/ncpcardio0047</ext-link><pub-id pub-id-type="pmid">16265313</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusch</surname><given-names>G</given-names></name></person-group>
<article-title>Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug?</article-title>
<source>Circulation</source>
<year>2001</year>;<volume>103</volume>:<fpage>2876</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/01.CIR.103.24.2876">doi:10.1161/01.CIR.103.24.2876</ext-link><pub-id pub-id-type="pmid">11413072</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>M</given-names></name>, <name><surname>Sasayama</surname><given-names>S</given-names></name>, <name><surname>Ohno</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Importance of angina for development of collateral circulation</article-title>. <source>Br Heart J</source>
<year>1987</year>;<volume>57</volume>:<fpage>139</fpage>&#x02013;<lpage>43</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/hrt.57.2.139">doi:10.1136/hrt.57.2.139</ext-link><pub-id pub-id-type="pmid">3814448</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname><given-names>RA</given-names></name>, <name><surname>Shook</surname><given-names>T</given-names></name>, <name><surname>Przyklenk</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?</article-title>
<source>Circulation</source>
<year>1995</year>;<volume>91</volume>:<fpage>37</fpage>&#x02013;<lpage>45</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/01.CIR.91.1.37">doi:10.1161/01.CIR.91.1.37</ext-link><pub-id pub-id-type="pmid">7805217</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimarino</surname><given-names>M</given-names></name>, <name><surname>D'Andreamatteo</surname><given-names>M</given-names></name>, <name><surname>Waksman</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The dynamics of the coronary collateral circulation</article-title>. <source>Nat Rev Cardiol</source>
<year>2014</year>;<volume>11</volume>:<fpage>191</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrcardio.2013.207">doi:10.1038/nrcardio.2013.207</ext-link><pub-id pub-id-type="pmid">24395049</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>M</given-names></name>, <name><surname>Horvath-Puho</surname><given-names>E</given-names></name>, <name><surname>Pedersen</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Time-dependent effect of preinfarction angina pectoris and intermittent claudication on mortality following myocardial infarction: a Danish nationwide cohort study</article-title>. <source>Int J Cardiol</source>
<year>2015</year>;<volume>187</volume>:<fpage>462</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2015.03.328">doi:10.1016/j.ijcard.2015.03.328</ext-link><pub-id pub-id-type="pmid">25846654</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>G</given-names></name>, <name><surname>Parodi</surname><given-names>G</given-names></name>, <name><surname>Sciagra</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty</article-title>. <source>Atherosclerosis</source>
<year>2013</year>;<volume>226</volume>:<fpage>153</fpage>&#x02013;<lpage>6</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.atherosclerosis.2012.09.008">doi:10.1016/j.atherosclerosis.2012.09.008</ext-link><pub-id pub-id-type="pmid">23190762</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T</given-names></name>, <name><surname>Shiomi</surname><given-names>H</given-names></name>, <name><surname>Toyota</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Effect of preinfarction angina pectoris on long-term survival in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention</article-title>. <source>Am J Cardiol</source>
<year>2014</year>;<volume>114</volume>:<fpage>1179</fpage>&#x02013;<lpage>86</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2014.07.038">doi:10.1016/j.amjcard.2014.07.038</ext-link><pub-id pub-id-type="pmid">25159235</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahn</surname><given-names>R</given-names></name>, <name><surname>Schiele</surname><given-names>R</given-names></name>, <name><surname>Schneider</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry)</article-title>. <source>Am J Cardiol</source>
<year>2001</year>;<volume>87</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0002-9149(00)01262-5">doi:10.1016/S0002-9149(00)01262-5</ext-link><pub-id pub-id-type="pmid">11137824</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferdinandy</surname><given-names>P</given-names></name>, <name><surname>Hausenloy</surname><given-names>DJ</given-names></name>, <name><surname>Heusch</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning</article-title>. <source>Pharmacol Rev</source>
<year>2014</year>;<volume>66</volume>:<fpage>1142</fpage>&#x02013;<lpage>74</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1124/pr.113.008300">doi:10.1124/pr.113.008300</ext-link><pub-id pub-id-type="pmid">25261534</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>P</given-names></name>, <name><surname>Hemingway</surname><given-names>H</given-names></name>, <name><surname>Lansky</surname><given-names>AJ</given-names></name><etal/></person-group>
<article-title>The impact of the coronary collateral circulation on mortality: a meta-analysis</article-title>. <source>Eur Heart J</source>
<year>2012</year>;<volume>33</volume>:<fpage>614</fpage>&#x02013;<lpage>21</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurheartj/ehr308">doi:10.1093/eurheartj/ehr308</ext-link><pub-id pub-id-type="pmid">21969521</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argaud</surname><given-names>L</given-names></name>, <name><surname>Rioufol</surname><given-names>G</given-names></name>, <name><surname>Lievre</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk</article-title>. <source>Eur Heart J</source>
<year>2004</year>;<volume>25</volume>:<fpage>2019</fpage>&#x02013;<lpage>25</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ehj.2004.07.040">doi:10.1016/j.ehj.2004.07.040</ext-link><pub-id pub-id-type="pmid">15541838</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billinger</surname><given-names>M</given-names></name>, <name><surname>Fleisch</surname><given-names>M</given-names></name>, <name><surname>Eberli</surname><given-names>FR</given-names></name><etal/></person-group>
<article-title>Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment?</article-title>
<source>J Am Coll Cardiol</source>
<year>1999</year>;<volume>33</volume>:<fpage>1027</fpage>&#x02013;<lpage>35</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0735-1097(98)00674-3">doi:10.1016/S0735-1097(98)00674-3</ext-link><pub-id pub-id-type="pmid">10091831</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>RJ</given-names></name>, <name><surname>Redwood</surname><given-names>SR</given-names></name>, <name><surname>Lambiase</surname><given-names>PD</given-names></name><etal/></person-group>
<article-title>Antiarrhythmic and anti-ischaemic effects of angina in patients with and without coronary collaterals</article-title>. <source>Heart</source>
<year>2002</year>;<volume>88</volume>:<fpage>604</fpage>&#x02013;<lpage>10</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/heart.88.6.604">doi:10.1136/heart.88.6.604</ext-link><pub-id pub-id-type="pmid">12433889</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Jim&#x000e9;nez</surname><given-names>R</given-names></name>, <name><surname>S&#x000e1;nchez-Gonz&#x000e1;lez</surname><given-names>J</given-names></name>, <name><surname>Ag&#x000fc;ero</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization</article-title>. <source>J Am Coll Cardiol</source>
<year>2015</year>;<volume>65</volume>:<fpage>315</fpage>&#x02013;<lpage>23</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2014.11.004">doi:10.1016/j.jacc.2014.11.004</ext-link><pub-id pub-id-type="pmid">25460833</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusch</surname><given-names>P</given-names></name>, <name><surname>Nensa</surname><given-names>F</given-names></name>, <name><surname>Heusch</surname><given-names>G</given-names></name></person-group>
<article-title>Is MRI really the gold standard for the quantification of salvage from myocardial infarction?</article-title>
<source>Circ Res</source>
<year>2015</year>;<volume>117</volume>:<fpage>222</fpage>&#x02013;<lpage>4</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCRESAHA.117.306929">doi:10.1161/CIRCRESAHA.117.306929</ext-link><pub-id pub-id-type="pmid">26185206</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>M</given-names></name>, <name><surname>Konstantinov</surname><given-names>IE</given-names></name>, <name><surname>Kharbanda</surname><given-names>RK</given-names></name><etal/></person-group>
<article-title>Effects of intermittent lower limb ischaemia on coronary blood flow and coronary resistance in pigs</article-title>. <source>Acta Physiol (Oxf)</source>
<year>2007</year>;<volume>190</volume>:<fpage>103</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1748-1716.2007.01667.x">doi:10.1111/j.1748-1716.2007.01667.x</ext-link><pub-id pub-id-type="pmid">17394577</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoole</surname><given-names>SP</given-names></name>, <name><surname>Heck</surname><given-names>PM</given-names></name>, <name><surname>White</surname><given-names>PA</given-names></name><etal/></person-group>
<article-title>Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary intervention</article-title>. <source>Angiology</source>
<year>2009</year>;<volume>60</volume>:<fpage>403</fpage>&#x02013;<lpage>11</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/0003319708328921">doi:10.1177/0003319708328921</ext-link><pub-id pub-id-type="pmid">19106155</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdouw</surname><given-names>PD</given-names></name>, <name><surname>van den Doel</surname><given-names>MA</given-names></name>, <name><surname>de Zeeuw</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Animal models in the study of myocardial ischaemia and ischaemic syndromes</article-title>. <source>Cardiovasc Res</source>
<year>1998</year>;<volume>39</volume>:<fpage>121</fpage>&#x02013;<lpage>35</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0008-6363(98)00069-8">doi:10.1016/S0008-6363(98)00069-8</ext-link><pub-id pub-id-type="pmid">9764194</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloth</surname><given-names>AD</given-names></name>, <name><surname>Schmidt</surname><given-names>MR</given-names></name>, <name><surname>Munk</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Impact of cardiovascular risk factors and medication use on the efficacy of remote ischaemic conditioning: post hoc subgroup analysis of a randomised controlled trial</article-title>. <source>BMJ Open</source>
<year>2015</year>;<volume>5</volume>:<fpage>e006923</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmjopen-2014-006923">doi:10.1136/bmjopen-2014-006923</ext-link></mixed-citation></ref></ref-list></back></article>